Heart rhythm breakthrough: drug and lifestyle combo targets AF
Prevention
Ongoing
This study tests whether the diabetes drug metformin, combined with lifestyle and risk factor changes, can reduce episodes of atrial fibrillation (AF) in people with pacemakers or defibrillators. About 175 participants with recent AF episodes will be randomly assigned to receive …
Phase: PHASE4 • Sponsor: Mina Chung, MD • Aim: Prevention
Last updated May 11, 2026 20:52 UTC